Trial Profile
TAXUS VI - A Randomized, Double-blind Study to Assess Paclitaxel-eluting Stents in Treatment of Longer Lesions
Status:
Completed
Phase of Trial:
Phase II/III
Latest Information Update: 10 Nov 2021
Price :
$35
*
At a glance
- Drugs Paclitaxel (Primary)
- Indications Angina pectoris; Coronary artery disease; Coronary artery restenosis; Coronary disorders; Myocardial ischaemia
- Focus Therapeutic Use
- Acronyms TAXUS-VI
- Sponsors Boston Scientific Corporation
- 30 Nov 2007 New trial record.